Well, as you know, we have 90+ indications, or per
Post# of 148282
So if we get a $10 partnership for mTNBC alone, then we go to $10.68 in a flash.
Will those other indications be valued for more? Probably, but how much more?
4-5x so maybe we go to $13. But the short squeeze which will mount will push it much higher, at least for a good sustained time in excess of 3-4 months where other possibilities may come to fruition.
That is Cyrus' job, to increase partnerships on all the indications CytoDyn developed and in doing so, share price to increase accordingly with the deals and with the shorts being squeezed out.